Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus.

Mulik S, Xu J, Reddy PB, Rajasagi NK, Gimenez F, Sharma S, Lu PY, Rouse BT.

Am J Pathol. 2012 Aug;181(2):525-34. doi: 10.1016/j.ajpath.2012.04.014. Epub 2012 May 31.

2.

IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection.

Suryawanshi A, Veiga-Parga T, Reddy PB, Rajasagi NK, Rouse BT.

J Immunol. 2012 Apr 1;188(7):3434-46. doi: 10.4049/jimmunol.1102602. Epub 2012 Feb 29.

3.
4.

Role of miR-155 in the pathogenesis of herpetic stromal keratitis.

Bhela S, Mulik S, Gimenez F, Reddy PB, Richardson RL, Varanasi SK, Jaggi U, Xu J, Lu PY, Rouse BT.

Am J Pathol. 2015 Apr;185(4):1073-84. doi: 10.1016/j.ajpath.2014.12.021. Epub 2015 Feb 18.

5.

An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology.

Sharma S, Mulik S, Kumar N, Suryawanshi A, Rouse BT.

J Virol. 2011 Jun;85(12):5995-6007. doi: 10.1128/JVI.00034-11. Epub 2011 Apr 6.

6.
7.

Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1.

Bhattacharjee PS, Neumann DM, Foster TP, Bouhanik S, Clement C, Vinay D, Thompson HW, Hill JM.

Exp Eye Res. 2008 Aug;87(2):122-30. doi: 10.1016/j.exer.2008.05.007. Epub 2008 May 18.

8.

Robo 4 Counteracts Angiogenesis in Herpetic Stromal Keratitis.

Gimenez F, Mulik S, Veiga-Parga T, Bhela S, Rouse BT.

PLoS One. 2015 Dec 31;10(12):e0141925. doi: 10.1371/journal.pone.0141925. eCollection 2015.

9.

Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor.

Suryawanshi A, Mulik S, Sharma S, Reddy PB, Sehrawat S, Rouse BT.

J Immunol. 2011 Mar 15;186(6):3653-65. doi: 10.4049/jimmunol.1003239. Epub 2011 Feb 16.

10.

CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.

Banerjee K, Biswas PS, Kim B, Lee S, Rouse BT.

J Immunol. 2004 Jan 15;172(2):1237-45.

11.

The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization.

Wuest T, Zheng M, Efstathiou S, Halford WP, Carr DJ.

PLoS Pathog. 2011 Oct;7(10):e1002278. doi: 10.1371/journal.ppat.1002278. Epub 2011 Oct 6.

12.

Suppression of transcription factor early growth response 1 reduces herpes simplex virus 1-induced corneal disease in mice.

Yao HW, Chen SH, Li C, Tung YY, Chen SH.

J Virol. 2012 Aug;86(16):8559-67. doi: 10.1128/JVI.00505-12. Epub 2012 May 30.

13.

Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions.

Rajasagi NK, Suryawanshi A, Sehrawat S, Reddy PB, Mulik S, Hirashima M, Rouse BT.

J Immunol. 2012 May 1;188(9):4631-43. doi: 10.4049/jimmunol.1103063. Epub 2012 Mar 30.

15.

Therapeutic potential of bevacizumab (Avastin) in herpetic stromal keratitis (HSK).

Hosseini H, Khalili MR.

Med Hypotheses. 2007;69(3):568-70. Epub 2007 Mar 21.

PMID:
17368959
16.
17.
18.

Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis.

Biswas PS, Banerjee K, Kim B, Kinchington PR, Rouse BT.

J Virol. 2005 Aug;79(16):10589-600. Erratum in: J Virol. 2005 Dec;79(24):15590.

19.

Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation.

Kim B, Sarangi PP, Lee Y, Deshpande Kaistha S, Lee S, Rouse BT.

J Leukoc Biol. 2006 Dec;80(6):1405-15. Epub 2006 Sep 22.

20.

Herpes simplex keratitis.

Kaye S, Choudhary A.

Prog Retin Eye Res. 2006 Jul;25(4):355-80. Epub 2006 Jun 27. Review.

PMID:
16807055
Items per page

Supplemental Content

Write to the Help Desk